Morita Hidetaka, Suematsu Yasunori, Morita Kai, Yano Yuiko, Sakamoto Maaya, Matsuda Takuro, Kaino Kouji, Teshima Reiko, Ura Nobuyuki, Fujita Masaomi, Tazawa Rie, Nakagawa Hironari, Kitajima Ken, Kamada Satoshi, Fujimi Kanta, Miura Shin-Ichiro
Department of Cardiology, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka 814-0180, Japan.
Center for Cardiac Rehabilitation, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka 814-0180, Japan.
J Clin Med. 2021 Jul 27;10(15):3306. doi: 10.3390/jcm10153306.
Cardiac rehabilitation (CR) is a requisite component of care for patients with heart failure (HF). We aimed to evaluate the clinical outcomes in outpatients with HF with preserved ejection fraction (HFpEF) compared to those in patients with non-HFpEF who did and did not continue a 5-month CR program.
173 outpatients with HF who participated in a 5-month CR program were registered. We divided them into two groups: HFpEF ( = 84, EF 63 ± 7%) and non-HFpEF ( = 89, EF 31 ± 11%). We further divided the patients into those who continued the CR program (continued group) and those who did not (discontinued group) in the HFpEF and non-HFpEF groups. The clinical outcomes at 5 months were compared among the groups.
There were no significant differences in patient characteristics at baseline between the continued and discontinued groups in the HFpEF and non-HFpEF groups except for % diabetes mellitus in the non-HFpEF group. The rates of all-cause death and hospital admissions in the continued group in both the HFpEF and non-HFpEF groups were significantly lower than those in the discontinued group. The all-cause death and hospital admissions in each group were independently associated with the continuation of the CR program.
The continuation of a 5-month CR program was associated with the prevention of all-cause death and hospital admissions in both the HFpEF and non-HFpEF groups.
心脏康复(CR)是心力衰竭(HF)患者护理的必要组成部分。我们旨在评估射血分数保留的心力衰竭(HFpEF)门诊患者与未患HFpEF且参加和未参加为期5个月CR项目的患者的临床结局。
登记了173名参加为期5个月CR项目的HF门诊患者。我们将他们分为两组:HFpEF组(n = 84,射血分数[EF]63±7%)和非HFpEF组(n = 89,EF 31±11%)。我们在HFpEF组和非HFpEF组中进一步将患者分为继续CR项目的患者(继续组)和未继续的患者(中断组)。比较了各组在5个月时的临床结局。
除了非HFpEF组的糖尿病百分比外,HFpEF组和非HFpEF组的继续组和中断组在基线时的患者特征没有显著差异。HFpEF组和非HFpEF组继续组的全因死亡率和住院率均显著低于中断组。每组的全因死亡和住院与CR项目的继续独立相关。
为期5个月的CR项目的继续与HFpEF组和非HFpEF组预防全因死亡和住院有关。